Hybrid Conferencee

International Conference on Hematology and Genetic Disorders (ICHGD - 27)

27th - 28th February 2027 | Sisimiut, Greenland
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Sisimiut. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Sisimiut event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Sisimiut conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Sisimiut, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Sisimiut."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Molecular Diagnostics for Hematological Disorders

This track will explore the latest innovations in molecular diagnostic techniques that enhance the detection and characterization of hematological disorders. Emphasis will be placed on the integration of genomic technologies in clinical practice.

Track 02

Translational Research in Hematology: Bridging Bench to Bedside

This session will focus on the translation of laboratory findings into clinical applications for hematological diseases. Discussions will include successful case studies and the challenges faced in implementing translational research.

Track 03

Clinical Trials in Hematology: Design and Implementation

This track will examine the methodologies and ethical considerations involved in designing and conducting clinical trials for hematological treatments. Participants will gain insights into recent trial outcomes and their implications for patient care.

Track 04

Innovative Therapeutic Strategies for Genetic Blood Disorders

This session will highlight novel therapeutic approaches for managing genetic disorders affecting the hematological system. Topics will include gene therapy, targeted therapies, and the role of personalized medicine.

Track 05

Biomarker Discovery in Hematology: Current Trends and Future Directions

This track will delve into the identification and validation of biomarkers relevant to hematological conditions. The focus will be on how these biomarkers can improve diagnosis, prognosis, and treatment strategies.

Track 06

Patient Care in Hematology: Best Practices and Innovations

This session will discuss the latest advancements in patient care for individuals with hematological disorders. Emphasis will be placed on multidisciplinary approaches and patient-centered care models.

Track 07

Laboratory Techniques in Hematology: Enhancements and Challenges

This track will cover the latest laboratory techniques used in the diagnosis and monitoring of hematological disorders. Participants will discuss the challenges faced in standardizing these techniques across different settings.

Track 08

Genetic Insights into Hematological Malignancies

This session will focus on the genetic underpinnings of hematological malignancies, including leukemias and lymphomas. Discussions will include the role of genetic mutations in disease progression and treatment response.

Track 09

Integrating Genomics into Hematology Practice

This track will explore the integration of genomic data into routine hematology practice for improved patient outcomes. Topics will include the challenges of data interpretation and the implications for personalized treatment plans.

Track 10

Emerging Therapies in Hematology: A Focus on Novel Agents

This session will highlight emerging therapeutic agents and their mechanisms of action in the treatment of hematological disorders. Participants will discuss the potential impact of these therapies on clinical practice.

Track 11

Ethical Considerations in Hematology Research and Practice

This track will address the ethical challenges faced in hematology research and clinical practice. Discussions will include informed consent, patient autonomy, and the implications of genetic testing.